Accelerating research in Parkinson’s with GBA
The Silverstein Foundation for Parkinson’s with GBA actively supports cutting edge research with the goal of discovering new therapies for the treatment of Parkinson’s Disease in glucocerebrosidase (GBA) mutation carriers.
We are actively involved in early stage programs that potentially could be appropriate for GBA mutation carriers
In the News
Watch videos and read news and press releases related to the Foundation and Parkinson’s with GBA.